It may seem as if publications on our hydrogen tablets, and hydrogen water in general, are all over the map. That’s because they are. Several of our consultants have criticized our eagerness to allow public teams to pursue a wide range of targets on our hydrogen tablets as it increases confusion in marketing said hydrogen tablets and delays […]

As alluded to in my conversation with Prof. Ostojic , an important secondary analysis was done on the study group used for our 3rd publication on NAFLD and it found something very important; hydrogen water, specifically the ultra-high dose from our tablets, increased insulin sensitivity by 11% in the small study in just 28 days. The results can

What is Nonalcoholic Fatty Liver Disease? Nonalcoholic fatty liver disease (NAFLD), or sometimes called “Simple Fatty Liver” is growing at an unprecedented rate in the US and Canada. Some current estimates have projected that upwards of 30% of North Americans are afflicted. In certain populations, this number is far more startling, with upwards of 80%